JPMorgan analyst Lisa Gill lowered the firm’s price target on Cardinal Health (CAH) to $215 from $243 and keeps a Neutral rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal, McKesson, Zeta, Centene, ABAT Trending With Analysts
- Cardinal Health price target lowered to $248 from $257 at Baird
- Cardinal Health price target raised to $255 from $251 at TD Cowen
- Cardinal Health price target lowered to $245 from $249 at Citi
- Cardinal Health Lifts 2026 Outlook After Strong Q3
